Insigneo Advisory Services LLC decreased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 41.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,429 shares of the company’s stock after selling 10,067 shares during the quarter. Insigneo Advisory Services LLC’s holdings in BlackRock Health Sciences Term Trust were worth $215,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Estabrook Capital Management acquired a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $35,000. Elequin Capital LP bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter worth $84,000. Yakira Capital Management Inc. acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter valued at $153,000. Virtu Financial LLC acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter valued at $206,000. Finally, K2 Principal Fund L.P. boosted its holdings in BlackRock Health Sciences Term Trust by 62.7% in the 4th quarter. K2 Principal Fund L.P. now owns 16,271 shares of the company’s stock valued at $234,000 after purchasing an additional 6,271 shares during the period.
BlackRock Health Sciences Term Trust Stock Performance
NYSE:BMEZ opened at $14.21 on Friday. The firm’s 50-day moving average is $14.33 and its 200-day moving average is $14.99. BlackRock Health Sciences Term Trust has a 52-week low of $12.58 and a 52-week high of $16.75.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Buy Gold Stock and Invest in Gold
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.